Diazepam tablets 2mg
Home A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Diazepam tablets 2mg



Ranzepam Tablets

7.12.2017 | Ashley Kendal
Diazepam tablets 2mg
Ranzepam Tablets

Ranzepam Tablets - Consumer Medicines Information leaflets of prescription Ranzepam tablets contain 2 mg or 5 mg of diazepam as the active ingredient.

They are usually mild and may disappear if the dose is reduced. The above list includes the more common side effects of diazepam.

These medicines include:. Some medicines may interfere with Ranzepam.

If you are not sure whether you should start taking diazepam, talk to your doctor.

If you are not sure what to do, contact your doctor or pharmacist.

Continuous long-term use is not recommended unless advised by your doctor.

Diazepam 10mg 2mg 5mg Pills, Tablets The High Effects Street

10.15.2017 | Natalie Carter
Diazepam tablets 2mg
Diazepam 10mg 2mg 5mg Pills, Tablets The High Effects Street

Take special care with Diazepam 10 mg tablets and try starting on a lower dosage such as 2mg or 5mg and do not take in these circumstances.

https://www.google.com/maps/d/viewer?mid=1hlYbt_Dc8wMEBvv_-Zo0LaxFV8g&ll=55. %2C-3. %2C-3. %2C-3. &z=5 https://www.google.com/maps/d/viewer?mid=12vAaPqdEB4EJZ9r2dd2u_f9XA1g&ll=55. &z=5 https://www.google.com/maps/d/viewer?mid=1IplSLfkU28MUzr-9ZGeuMrdZ4sg&ll=55. &z=5 https://www.google.com/maps/d/viewer?mid=1jMqfv6mFLpOOZL9oHFM_qM7iKpk&ll=55. &z=5 https://www.google.com/maps/d/viewer?mid=1gkWnjAdd1sEofxBBc2jEJZMCxEk&ll=55. &z=5 https://www.google.com/maps/d/viewer?mid=1QCbl_4ONKDcAGXHpwYeOqMpsc5c&ll=55.

Diazepam 2mg

3.8.2017 | Nicholas Babcock
Diazepam tablets 2mg

院內簡碼. Diazepam 2mg. 商品名. DIAZEPAM TABLETS(鋁箔). 中文名. "景德"丹祈屏錠2公絲. 主成份. DIAZEPAM. 劑型. 錠劑. 許可證字號. 衛署藥製字第001646號.

Diazepam 2mg 院內簡碼 Diazepam 2mg 商品名 DIAZEPAM TABLETS(鋁箔) 中文名 "景德"丹祈屏錠2公絲 主成份 DIAZEPAM 劑型 錠劑 許可證字號 衛署藥製字第001646號 藥廠名稱 景德製藥股份有限公司土城廠 藥理治療分類 苯二氮平衍生物 孕婦等級 D 外觀描述 白色,圓扁形 適應症 焦慮狀態、失眠、肌肉痙攣 用法用量

1.成人: a.抗焦慮劑、安眠劑:一天5~30mg睡前一次或分次給,一天2~4 次。 b.急性酒精戒斷:第一次10mg,此後視需要一天3~4 次,劑量以能維持鎮靜為原則。 c.抗痙攣劑:2~10mg,一天3~4 次。 d.骨骼肌鬆弛:2~10mg,一天3~4 次。 2.年老及體弱病人:2~2.5mg,一天1~2 次,視需要及耐受性逐漸增加劑量。 3.一般兒童劑量:6 歲以下兒童不宜使用。 4.6 歲及6 歲以上兒童:1~2.5mg或每公斤體重0.04mg~0.2mg(40~200mcg),每平方公尺體表面積1.17~6mg,一天3~4 次,視需要及耐受性逐漸增加劑量。 副作用 1.嗜睡、鎮靜、運動失調。 2.高劑量可能發生呼吸抑制和低血壓。 3當出現耐受性時,會發生反彈性焦慮及失眠。 禁忌 昏迷、急性肺功能不足、睡眠窒息、肌肉無力、肝或腎功能傷害、急性狹窄性青光眼、慢性精神病有畏懼的狀態、嚴重心臟病患者。 注意事項

1.老年人和體弱的病人,建議劑量降至最低有效量,以排除出現精神安定或過度鎮靜(初劑量1天或2天2mg~2 1/2mg,而後慢慢增加到所需要量及容許量)。 2.服藥後,開車或操作危險機械時,應格外小心。 3.長期服用此藥,可能造成藥物成癮性或依賴性。 4.服用此藥3至4個月後,不能突然停藥,因為突然停藥可能造成戒斷症狀。 5.避免與酒精併服。 6.本藥之使用應小心考慮: a.急性酒精中毒,並有抑制生命力徵象(因為有相加性中樞神經系統抑制作用) b.曾濫用藥物或有依賴性者(有產生習慣及依賴性的因素) c.癲癇(開始或突然戒斷本藥,可能增加大發作之頻度與嚴重性,靜脈使用本藥於小發作可能產生強直性癲癇重積狀態) d.肝功能受損害(排除半衰期可能延長) e.低血清白蛋白(使病人易傾向於鎮靜副作用) f.嚴重的精神抑制(可能有自殺傾向,故須要有保護措施,單獨使用本藥也有可能增加抑制) g.重症肌無力症(本藥會產生肌肉鬆弛的作用) h.急性狹角性青光眼或有此傾向者(因為有抗膽鹼的作用的可能) i.精神病(本藥作為精神病患主要治療劑很少有效,還可能產生矛盾性反應) j.嚴重慢性阻塞肺部疾病(氣道衰竭可能更惡化) k.腎功能受損(可能延長藥物之排除)。 交互作用

1.Antacids 與本藥合用會延遲但不會減低本藥之吸收。 2.Cimetidine 與本藥合用,會抑制本藥於肝之氧化代謝,而增加本藥之血中濃度。 3.本藥與其它中樞神經抑制劑如:酒精、止痛劑、全身麻醉劑及Tricyclic antidepressants 合用時,會增加這些藥物或本藥的作用。 4.Isoniazid 與本藥合用,會抑制本藥之排除而增加血漿濃度,故需調整劑量。 5.Phenytoin 與本藥合用,會改變Phenytoin 之血清濃度。 6.Rifampin 與本藥合用時,會促進本藥之排除,而減少血漿濃度,故需調整劑量。 7.與其他抗精神病藥物或抗驚厥性藥物併用,必須注意使用藥品的藥物學,特別是使用已知可能增強本品效果的化合物Phenothiazines,麻醉劑,巴比妥類,MAO抑制劑和其他抗憂鬱劑。

Diazepam tablets 2mg bp

6.11.2017 | Natalie Carter
Diazepam tablets 2mg

To view details for DIAZEPAM TABLETS 2MG BP, please read and accept the disclaimer or go back to product listing for DIAZEPAM. I have read and understand.

Enter a product or active substance:

Search SPC and PILs.

I understand that this information may be updated several times within its shelf life, and that there could be differences between the version of the information shown here and other information in the public domain.

I understand that the MHRA has used its best endeavours in publishing this information, but accept that the information may not be the most up to date version for this product.

Please read the following information and tick the box to proceed to view the product information in pdf format.

leaflet MAH GENERIC_PL. Product Name: DIAZEPAM TABLETS 2MG BP 1. pdf (65Kb) Crown 2017 Head office : 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ General enquiries:. pdf (78Kb) 2. I have read and understand the disclaimer. spc-doc_PL.

This page shows the Summary of Product Characteristics (SPC) and patient information leaflet (PIL) for the product.

Patients should not stop taking any prescribed medicines without first speaking to a healthcare professional. Suspected adverse reactions to a medicine can be reported to us on a Yellow Card. I understand that the MHRA is unable to offer medical advice and that if a patient has any questions about a medicine they are taking they should contact their doctor or pharmacist.

Products with a UK marketing authorisation have a licence number in the format 'PL 12345/0001'. The product licence number can be found on the packaging of the product. Before a medicine can be sold in the UK, a number of licences are essential. You can identify the product in the list below using the PL number in the links below. The first two characters are always the letters 'PL'.

Disclaimer: I understand that this information is a copy of the Summary of Product Characteristics and patient information leaflet for a medicine, which outline the conditions under which the medicine should be used and information on its known safety.

Diazepam 2mg Tablets

5.10.2017 | Natalie Carter
Diazepam tablets 2mg

(Teva UK Limited) results of assays carried out during routine stability studies did not comply with the required specification – class 3 action within 5 days.

uses cookies to make the site simpler. Find out more about cookies.

From: Medicines and Healthcare products Regulatory Agency.

Local area teams are asked to bring this information to the attention of community pharmacists, general practitioners, dental practitioners and extended formulary nurse prescribers by copy of this letter.

Class 3 medicines recall.

Issued: 24 April 2013.

Don’t include personal or financial information like your National Insurance number or credit card details. Open Government Licence.

(Teva UK Limited) results of assays carried out during routine stability studies did not comply with the required specification – class 3 action within 5 days. (EL 13(A)11) 24 April 2013.

Alert type: Drug alert Medical specialism: Pharmacy.

Action within 5 days Pharmacy-level recall MDR 50-04/13 Teva UK Limited Diazepam 2mg Tablets PL 00289/0164.

Teva UK Limited is recalling all remaining stock of the above batches because the results of assays carried out during routine stability studies did not comply with the required specification.

For further stock enquiries please contact Teva UK Customer Service Team on 0800 590502. Remaining stocks of these batches should be quarantined and returned to the original supplier for credit.

For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by to.

Published: 17 December 2014.

All content is available under the Open Government Licence v3.0, except where otherwise stated.